Neogen Chemicals Ltd is Rated Sell

2 hours ago
share
Share Via
Neogen Chemicals Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 22 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Neogen Chemicals Ltd is Rated Sell

Current Rating and Its Significance

MarketsMOJO’s 'Sell' rating for Neogen Chemicals Ltd indicates a cautious stance towards the stock, suggesting that investors may want to consider reducing their exposure or avoid initiating new positions at this time. This rating reflects a comprehensive evaluation of the company’s quality, valuation, financial trend, and technical outlook as of today, rather than solely relying on past performance or the date of the rating change.

Quality Assessment

As of 15 May 2026, Neogen Chemicals exhibits an average quality grade. The company’s ability to generate returns on equity remains modest, with an average Return on Equity (ROE) of 9.65%. This figure points to relatively low profitability per unit of shareholders’ funds, which may concern investors seeking robust earnings efficiency. Additionally, the company’s capacity to service its debt is limited, as evidenced by a high Debt to EBITDA ratio of 8.54 times. This elevated leverage level increases financial risk, particularly in volatile market conditions or economic downturns.

Valuation Perspective

The stock is currently classified as very expensive based on valuation metrics. Despite trading at a discount relative to its peers’ historical averages, Neogen Chemicals’ Enterprise Value to Capital Employed ratio stands at 3.2, signalling a premium valuation in the context of its financial performance. This expensive valuation is not fully supported by the company’s earnings or cash flow generation, which may limit upside potential for investors and increase downside risk if earnings disappoint further.

Financial Trend and Profitability

The financial trend for Neogen Chemicals is decidedly negative. The company has reported a significant decline in profitability, with Profit Before Tax (PBT) falling by 39.95% in the most recent quarter. This marks the third consecutive quarter of negative results, underscoring ongoing operational challenges. The latest six-month Profit After Tax (PAT) stands at ₹7.06 crores, reflecting a steep contraction of 66.33% compared to prior periods. Furthermore, the Return on Capital Employed (ROCE) is low at 5.72%, and the operating profit to interest coverage ratio is just 1.48 times, indicating tight margins and limited buffer to meet interest obligations.

Technical Outlook

On a technical front, the stock shows a bullish grade, suggesting that market sentiment and price momentum have been positive recently. Over the past six months, Neogen Chemicals has delivered a 38.15% return, with a year-to-date gain of 42.03%. The one-year return is more modest at 8.11%, reflecting volatility and mixed investor sentiment. Despite the positive technical signals, these gains have not been supported by improving fundamentals, which remain a concern for long-term investors.

Stock Performance Summary

As of 15 May 2026, Neogen Chemicals’ stock price has experienced mixed movements. The one-day change is a slight increase of 0.12%, while the one-week return shows a decline of 5.21%. The one-month and three-month returns are more encouraging at 16.01% and 30.62% respectively, indicating some recovery or speculative interest. However, the longer-term profitability challenges and high leverage temper enthusiasm for the stock’s outlook.

Implications for Investors

Investors should interpret the 'Sell' rating as a signal to exercise caution. The combination of average quality, very expensive valuation, deteriorating financial trends, and mixed technical signals suggests that the stock carries elevated risk. Those holding Neogen Chemicals shares may consider reviewing their positions in light of the company’s weak profitability and high debt levels. Prospective investors should weigh the potential for short-term price gains against the fundamental challenges that could limit sustainable growth.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

Contextualising the Rating

The 'Sell' rating reflects a balanced view that, while the stock has shown some positive price momentum recently, the underlying fundamentals remain weak. The company’s poor debt servicing ability and declining profitability are key factors weighing on the rating. Investors should be aware that the valuation remains stretched relative to the company’s financial health, which could limit upside potential and increase vulnerability to market corrections.

Sector and Market Position

Neogen Chemicals operates within the specialty chemicals sector, a space often characterised by cyclical demand and sensitivity to raw material costs. The company’s small-cap status adds an additional layer of risk due to lower liquidity and potentially higher volatility. Compared to peers, Neogen Chemicals’ valuation discount is modest and does not fully compensate for its weaker financial metrics. This context is important for investors considering sector allocation and risk diversification.

Conclusion

In summary, Neogen Chemicals Ltd’s current 'Sell' rating by MarketsMOJO, updated on 22 Apr 2026, is grounded in a thorough analysis of the company’s present-day fundamentals as of 15 May 2026. The stock’s average quality, very expensive valuation, negative financial trend, and bullish technical signals combine to form a complex investment profile. While recent price gains may attract some investors, the underlying financial challenges suggest prudence is warranted. Investors should carefully assess their risk tolerance and investment horizon before considering exposure to this stock.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News